RT Journal Article
T1 Factors that Influence Treatment Delay for Patients with Breast Cancer
A1 Padilla-Ruiz, María
A1 Zarcos-Pedrinaci, Irene
A1 Rivas-Ruiz, Francisco
A1 Téllez-Santana, Teresa
A1 García-Gutiérrez, Susana
A1 González, Nerea
A1 Rivero, Amado
A1 Sarasqueta Cristina, 
A1 Serrano-Aguilar, Pedro
A1 Castells, Xavier
A1 Quintana, José María
A1 Sala, María
A1 Redondo-Bautista, Maximino
A1 Comas, Mercè
A1 Domingo, Laia
A1 Macià, Francesc
A1 Roman, Marta
A1 Romero, Anabel
A1 Barata, Teresa
A1 de la Lastra, Isabel Diez
A1 de la Vega, Mariola
A1 Bare, María
A1 Torà, Núria
A1 Ferrer, Joana
A1 Castanyer, Francesc
A1 Carmona, Carmen
A1 García, Susana
A1 Martín, Maximina
A1 González, Nerea
A1 Orive, Miren
A1 Valverde, María Amparo
A1 Saez, Alberto
A1 Barredo, Inma
A1 de Toro, Manuel
A1 Ferreiro, Josefa
A1 Pérez, Jeanette
A1 Valcárcel, Cristina
A1 Churruca, Cristina
A1 Perales, Amaia
A1 Recio, Javier
A1 Ruiz. Irune, 
A1 Urraca, José María
A1 Michelena, María Jesús
A1 Moreno, Javier
A1 Mallabiabarrena, Gaizka
A1 Cobos, Patricia
A1 Otero, Borja
A1 Gorostiaga, Javier
A1 Troya, Itsaso
K1 Mamas - Cáncer
AB Introduction: The diagnosis or treatment of breast cancer is sometimes delayed. A lengthy delay may have a negative psychological impact on patients. The aim of our study was to evaluate the sociodemographic, clinical and pathological factors associated with delay in the provision of surgical treatment for localised breast cancer, in a prospective cohort of patients.Methods: This observational, prospective, multicentre study was conducted in ten hospitals belonging to the Spanish national public health system, located in four Autonomous Communities (regions). The study included 1236 patients, diagnosed through a screening programme or found to be symptomatic, between April 2013 and May 2015. The study variables analysed included each patient's personal history, care situation, tumour history and data on the surgical intervention, pathological anatomy, hospital admission and follow-up. Treatment delay was defined as more than 30 days elapsed between biopsy and surgery.Results: Over half of the study population experienced surgical treatment delay. This delay was greater for patients with no formal education and among widows, persons not requiring assistance for usual activities, those experiencing anxiety or depression, those who had a high BMI or an above-average number of comorbidities, those who were symptomatic, who did not receive NMR spectroscopy, who presented a histology other than infiltrating ductal carcinoma or who had poorly differentiated carcinomas.Conclusions: Certain sociodemographic and clinical variables are associated with surgical treatment delay. This study identifies factors that influence surgical delays, highlighting the importance of preventing these factors and of raising awareness among the population at risk and among health personnel.
PB Springer Nature
SN 1068-9265
YR 2021
FD 2021-07-01
LK https://hdl.handle.net/10630/45291
UL https://hdl.handle.net/10630/45291
LA eng
NO Padilla-Ruiz, M., Zarcos-Pedrinaci, I., Rivas-Ruiz, F., Téllez, T., García-Gutiérrez, S., González, N., Rivero, A., Sarasqueta, C., Serrano-Aguilar, P., Castells, X., Quintana, J. M., Sala, M., Redondo, M., REDISSEC-CaMISS Group, Castells, X., Comas, M., Domingo, L., Macià, F., Roman, M., Romero, A., … Troya, I. (2021). Factors that Influence Treatment Delay for Patients with Breast Cancer. Annals of surgical oncology, 28(7), 3714–3721. https://doi.org/10.1245/s10434-020-09409-2
NO Carlos III Health Institute through Projects PI12/01842 and PI12/02493
NO Andalusian Ministry of Health through Project 16/298 (co-funded by the European Social Fund/European Regional Development Fund ‘‘Investing in your future’’)
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 13 abr 2026